nodes	percent_of_prediction	percent_of_DWPC	metapath
Ximelagatran—F2—FOXA2 and FOXA3 transcription factor networks—CEBPA—head and neck cancer	0.0859	0.0859	CbGpPWpGaD
Ximelagatran—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—head and neck cancer	0.0434	0.0434	CbGpPWpGaD
Ximelagatran—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—head and neck cancer	0.0395	0.0395	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—SOD2—head and neck cancer	0.0322	0.0322	CbGpPWpGaD
Ximelagatran—F2—G alpha (q) signalling events—KISS1—head and neck cancer	0.027	0.027	CbGpPWpGaD
Ximelagatran—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.0267	0.0267	CbGpPWpGaD
Ximelagatran—F2—Peptide ligand-binding receptors—KISS1—head and neck cancer	0.0266	0.0266	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—SOD2—head and neck cancer	0.0262	0.0262	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—GPX1—head and neck cancer	0.025	0.025	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—KISS1—head and neck cancer	0.0241	0.0241	CbGpPWpGaD
Ximelagatran—F2—G alpha (q) signalling events—GRP—head and neck cancer	0.0222	0.0222	CbGpPWpGaD
Ximelagatran—F2—Peptide ligand-binding receptors—GRP—head and neck cancer	0.0219	0.0219	CbGpPWpGaD
Ximelagatran—CYP2C9—Xenobiotics—CYP1A1—head and neck cancer	0.0209	0.0209	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—SOD2—head and neck cancer	0.0208	0.0208	CbGpPWpGaD
Ximelagatran—F2—IL1 and megakaryotyces in obesity—PIK3CA—head and neck cancer	0.0203	0.0203	CbGpPWpGaD
Ximelagatran—CYP2C9—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.0201	0.0201	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—GRP—head and neck cancer	0.0199	0.0199	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—GPX1—head and neck cancer	0.0198	0.0198	CbGpPWpGaD
Ximelagatran—F2—Thrombin signalling through proteinase activated receptors (PARs)—MAPK3—head and neck cancer	0.0195	0.0195	CbGpPWpGaD
Ximelagatran—F2—Thrombin signalling through proteinase activated receptors (PARs)—MAPK1—head and neck cancer	0.0186	0.0186	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—KISS1—head and neck cancer	0.0179	0.0179	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—GRP—head and neck cancer	0.0147	0.0147	CbGpPWpGaD
Ximelagatran—F2—Angiopoietin receptor Tie2-mediated signaling—MAPK3—head and neck cancer	0.0137	0.0137	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—IL2—head and neck cancer	0.0136	0.0136	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—KISS1—head and neck cancer	0.0136	0.0136	CbGpPWpGaD
Ximelagatran—F2—Angiopoietin receptor Tie2-mediated signaling—MAPK1—head and neck cancer	0.013	0.013	CbGpPWpGaD
Ximelagatran—F2—PAR1-mediated thrombin signaling events—PIK3CA—head and neck cancer	0.0127	0.0127	CbGpPWpGaD
Ximelagatran—F2—Platelet Aggregation (Plug Formation)—AKT1—head and neck cancer	0.0117	0.0117	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—PTGS2—head and neck cancer	0.0117	0.0117	CbGpPWpGaD
Ximelagatran—F2—Angiopoietin receptor Tie2-mediated signaling—PIK3CA—head and neck cancer	0.0113	0.0113	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—GRP—head and neck cancer	0.0112	0.0112	CbGpPWpGaD
Ximelagatran—F2—FOXA2 and FOXA3 transcription factor networks—AKT1—head and neck cancer	0.0102	0.0102	CbGpPWpGaD
Ximelagatran—CYP2C9—Arachidonic acid metabolism—GPX1—head and neck cancer	0.0101	0.0101	CbGpPWpGaD
Ximelagatran—CYP2C9—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.01	0.01	CbGpPWpGaD
Ximelagatran—F2—Angiopoietin receptor Tie2-mediated signaling—AKT1—head and neck cancer	0.00922	0.00922	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—TP53—head and neck cancer	0.00875	0.00875	CbGpPWpGaD
Ximelagatran—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.00866	0.00866	CbGpPWpGaD
Ximelagatran—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.00855	0.00855	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—NAT2—head and neck cancer	0.00797	0.00797	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—GRP—head and neck cancer	0.00788	0.00788	CbGpPWpGaD
Ximelagatran—CYP2C9—Metapathway biotransformation—NAT2—head and neck cancer	0.00786	0.00786	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—KISS1—head and neck cancer	0.00769	0.00769	CbGpPWpGaD
Ximelagatran—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.00702	0.00702	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—KISS1—head and neck cancer	0.00698	0.00698	CbGpPWpGaD
Ximelagatran—F2—Cell surface interactions at the vascular wall—PIK3CA—head and neck cancer	0.00654	0.00654	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—GRP—head and neck cancer	0.00633	0.00633	CbGpPWpGaD
Ximelagatran—F2—Cell surface interactions at the vascular wall—HRAS—head and neck cancer	0.00605	0.00605	CbGpPWpGaD
Ximelagatran—CYP2C9—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.00596	0.00596	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—GRP—head and neck cancer	0.00575	0.00575	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—MAPK3—head and neck cancer	0.00571	0.00571	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—MAPK1—head and neck cancer	0.00543	0.00543	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—EGFR—head and neck cancer	0.00543	0.00543	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—IL2—head and neck cancer	0.00518	0.00518	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—PIK3CA—head and neck cancer	0.00471	0.00471	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—VEGFA—head and neck cancer	0.0044	0.0044	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—head and neck cancer	0.00426	0.00426	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—MAPK3—head and neck cancer	0.00416	0.00416	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—KISS1—head and neck cancer	0.00413	0.00413	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—head and neck cancer	0.00405	0.00405	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—head and neck cancer	0.00405	0.00405	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—MAPK1—head and neck cancer	0.00396	0.00396	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—GSTM1—head and neck cancer	0.00393	0.00393	CbGpPWpGaD
Ximelagatran—F2—G alpha (q) signalling events—PIK3CA—head and neck cancer	0.00393	0.00393	CbGpPWpGaD
Ximelagatran—CYP2C9—Metapathway biotransformation—GSTM1—head and neck cancer	0.00388	0.00388	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—CYP1A1—head and neck cancer	0.00373	0.00373	CbGpPWpGaD
Ximelagatran—CYP2C9—Metapathway biotransformation—CYP1A1—head and neck cancer	0.00368	0.00368	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—head and neck cancer	0.00351	0.00351	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—PIK3CA—head and neck cancer	0.00344	0.00344	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—GRP—head and neck cancer	0.0034	0.0034	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—STAT6—head and neck cancer	0.0033	0.0033	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—UROD—head and neck cancer	0.00328	0.00328	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—head and neck cancer	0.00325	0.00325	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—YAP1—head and neck cancer	0.00292	0.00292	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—AKT1—head and neck cancer	0.00281	0.00281	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—IL2—head and neck cancer	0.00267	0.00267	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.00255	0.00255	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—VEGFA—head and neck cancer	0.00227	0.00227	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—MAPK3—head and neck cancer	0.00215	0.00215	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—MAPK1—head and neck cancer	0.00204	0.00204	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—PIK3CA—head and neck cancer	0.00177	0.00177	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—TP53—head and neck cancer	0.00171	0.00171	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—IL2—head and neck cancer	0.00169	0.00169	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—HRAS—head and neck cancer	0.00164	0.00164	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—IL2—head and neck cancer	0.00153	0.00153	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—AKT1—head and neck cancer	0.00145	0.00145	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.00145	0.00145	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.00143	0.00143	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—NAT2—head and neck cancer	0.00136	0.00136	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NOTCH1—head and neck cancer	0.00132	0.00132	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—MAPK3—head and neck cancer	0.00123	0.00123	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—DPYD—head and neck cancer	0.00119	0.00119	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—MAPK1—head and neck cancer	0.00117	0.00117	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—EGFR—head and neck cancer	0.00117	0.00117	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—YAP1—head and neck cancer	0.00113	0.00113	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—PIK3CA—head and neck cancer	0.00112	0.00112	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PIK3CA—head and neck cancer	0.00102	0.00102	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—HRAS—head and neck cancer	0.000941	0.000941	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—AKT1—head and neck cancer	0.000915	0.000915	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IL2—head and neck cancer	0.000905	0.000905	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CCND1—head and neck cancer	0.000882	0.000882	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.000852	0.000852	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PTEN—head and neck cancer	0.000852	0.000852	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—AKT1—head and neck cancer	0.000831	0.000831	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—VEGFA—head and neck cancer	0.000769	0.000769	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—STAT3—head and neck cancer	0.000762	0.000762	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.000743	0.000743	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MAPK3—head and neck cancer	0.000728	0.000728	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MAPK1—head and neck cancer	0.000692	0.000692	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—EGFR—head and neck cancer	0.000692	0.000692	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—TYMS—head and neck cancer	0.000681	0.000681	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GSTM1—head and neck cancer	0.000673	0.000673	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GPX1—head and neck cancer	0.000644	0.000644	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CYP1A1—head and neck cancer	0.000638	0.000638	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PIK3CA—head and neck cancer	0.000601	0.000601	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TP53—head and neck cancer	0.000581	0.000581	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—HRAS—head and neck cancer	0.000556	0.000556	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	0.000524	0.000524	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—AKT1—head and neck cancer	0.000491	0.000491	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PTGS2—head and neck cancer	0.000379	0.000379	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PTEN—head and neck cancer	0.000331	0.000331	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PIK3CA—head and neck cancer	0.000233	0.000233	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—AKT1—head and neck cancer	0.000191	0.000191	CbGpPWpGaD
